Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Neurology. 2004 Jun 8;62(11):2106-9.

An open study of tacrolimus therapy in Rasmussen encephalitis.

Author information

  • 1Department of Epileptology, University of Bonn, Germany. c.bien@uni-bonn.de

Abstract

Seven patients with Rasmussen encephalitis (RE) were treated with the immunosuppressant tacrolimus and followed for a median of 22.4 months. They were compared with 12 historical untreated RE patients (median follow-up 13.9 months). The tacrolimus-treated patients had a superior outcome regarding neurologic function and progression rate of cerebral hemiatrophy but no better seizure outcome. No treated patient, but 7 of 12 control patients, became eligible for hemispherectomy. Tacrolimus did not have any major side effects.

PMID:
15184626
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Write to the Help Desk